Agios Reports Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Agios Pharma (AGIO) Tops Q4 EPS by 12c
February 13, 2020 7:23 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.60), $0.12 better than the analyst estimate of ($1.72). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $33.72 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More